|
1
|
Declèves AE and Sharma K: New
pharmacological treatments for improving renal outcomes in
diabetes. Nat Rev Nephrol. 6:371–380. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ruggenenti P and Remuzzi G: Nephropathy of
type 1 and type 2 diabetes: Diverse pathophysiology, same
treatment? Nephrol Dial Transplant. 15:1900–1902. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kanwar YS, Sun L, Xie P, Liu FY and Chen
S: A glimpse of various pathogenetic mechanisms of diabetic
nephropathy. Annu Rev Pathol. 6:395–423. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cheng H and Harris RC: Renal endothelial
dysfunction in diabetic nephropathy. Cardiovasc Hematol Disord Drug
Targets. 14:22–33. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mogensen CE: Microalbuminuria predicts
clinical proteinuria and early mortality in maturity-onset
diabetes. N Engl J Med. 310:356–360. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Rossing K, Christensen PK, Hovind P,
Tarnowl L, Rossing P and Parving HH: Progression of nephropathy in
type 2 diabetic patients. Kidney Int. 66:1596–1605. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gonzalez Suarez ML, Thomas DB, Barisoni L
and Fornoni A: Diabetic nephropathy: Is it time yet for routine
kidney biopsy? World J Diabetes. 4:245–255. 2013.PubMed/NCBI
|
|
8
|
Hillege HL, Janseen WM, Bak AA, Diercks
GF, Grobbee DE, Crijns HJ, Van Gilst WH, De Zeeuw D and De Jong PE:
Prevend Study Group: Microalbuminuria is common, also in a
nondiabetic, no hypertensive population and an independent
indicator of cardiovascular risk factors and cardiovascular
morbidity. J Intern Med. 249:519–526. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tabaei BP, Al-Kassab AS, Ilag LL, Zawacki
CM and Herman WH: Does microalbuminuria predict diabetic
nephropathy? Diabetes Care. 24:1560–1566. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jeon YK, Kim MR, Huh JE, Mok JY, Song SH,
Kim SS, Kim BH, Lee SH, Kim YK and Kim IJ: Cystatin C as an early
biomarker of nephropathy in patients with type 2 diabetes. J Korean
Med Sci. 26:258–263. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Oddoze C, Morange S, Portugal H, Berland Y
and Dussol B: Cystatin C is not more sensitive than creatinine for
detecting early renal impairment in patients with diabetes. Am J
Kidney Dis. 38:310–316. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Pillai RS, Bhattacharyya SN and Filipowicz
W: Repression of protein synthesis by miRNAs: How many mechanisms?
Trends Cell Biol. 17:118–126. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ardekani AM and Naeini M: The role of
microRNAs in human diseases. Avicenna J Med Biotechnol. 2:161–179.
2010.PubMed/NCBI
|
|
15
|
Pandey AK, Agarwal P, Kaur K and Datta M:
MicroRNAs in diabetes: Tiny players in big disease. Cell Physiol
Biochem. 23:221–232. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bhatt K, Mi QS and Dong Z: MicroRNAs in
kidneys: Biogenesis, regulation, and pathophysiological roles. Am J
Physiol Renal Physiol. 300:F602–F610. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kato M, Arce L and Natarajan R: MicroRNAs
and their role in progressive kidney diseases. Clin J Am Soc
Nephrol. 4:1255–1266. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Weber JA, Baxter DH, Zhang S, Huang DY,
Huang KH, Lee MJ, Galas DJ and Wang K: The microRNA spectrum in 12
body fluids. Clin Chem. 56:1733–1741. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mitchell PS, Parkin RK, Kroh EM, Fritz BR,
Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant
KC, Allen A, et al: Circulating microRNAs as stable blood-based
markers for cancer detection. Proc Natl Acad Sci USA.
105:10513–10518. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Etheridge A, Lee I, Hood L, Galas D and
Wang K: Extracellular microRNA: A new source of biomarkers. Mutat
Res. 717:85–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K,
Guo L, Zhang Y, Chen J, Guo X, et al: Characterization of microRNAs
in serum: A novel class of biomarkers for diagnosis of cancer and
other diseases. Cell Res. 18:997–1006. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Al-Kafaji G, Al-Mahroos G, Alsayed NA,
Hasan ZA, Nawaz S and Bakhiet M: Peripheral blood microRNA-15a is a
potential biomarker for type 2 diabetes mellitus and pre-diabetes.
Mol Med Rep. 12:7485–7490. 2015.PubMed/NCBI
|
|
23
|
Meder B, Keller A, Vogel B, Haas J,
Sedaghat-Hameddani F, Kayvanpour E, Just S, Borries A, Rudloff J,
Leidinger P, et al: MicroRNA signatures in total peripheral blood
as novel biomarkers for acute myocardial infarction. Basic Res
Cardiol. 106:13–23. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang S, Aurora AB, Johnson BA, Qi X,
McAnally J, Hill JA, Richardson JA, Bassel-Duby R and Olson EN: The
endothelial-specific microRNA miR-126 governs vascular integrity
and angiogenesis. Dev Cell. 15:261–271. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zampetaki A, Kiechl S, Drozdov I, Willeit
P, Mayr U, Prokopi M, Mayr A, Weger S, Oberhollenzer F, Bonora E,
et al: Plasma microRNA profiling reveals loss of endothelial
miR-126 and other microRNAs in type 2 diabetes. Circ Res.
107:810–817. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ortega FJ, Mercader JM, Moreno-Navarrete
JM, Rovira O, Guerra E, Esteve E, Xifra G, Martínez C, Ricart W,
Rieusset J, et al: Profiling of circulating microRNAs reveals
common microRNAs linked to type 2 diabetes that change with insulin
sensitization. Diabetes Care. 37:1375–1383. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Liu Y, Gao G, Yang C, Zhou K, Shen B,
Liang H and Jiang X: The role of circulating microRNA-126
(miR-126): A novel biomarker for screening prediabetes and newly
diagnosed type 2 diabetes mellitus. Int J Mol Sci. 15:10567–10577.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bijkerk R, Duijs JM, Khairoun M, Ter Horst
CJ, van der Pol P, Mallat MJ, Rotmans JI, de Vries AP, de Koning
EJ, de Fijter JW, et al: Circulating microRNAs associate with
diabetic nephropathy and systemic microvascular damage and
normalize after simultaneous pancreas-kidney transplantation. Am J
Transplant. 15:1081–1090. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang H, Peng W, Shen X, Huang Y, Ouyang X
and Dai Y: Circulating levels of inflammation-associated miR-155
and endothelial-enriched miR-126 in patients with end-stage renal
disease. Braz J Med Biol Res. 45:1308–1314. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Alberti KG and Zimmet PZ: Definition,
diagnosis and classification of diabetes mellitus and its
complications. Part 1: Diagnosis and classification of diabetes
mellitus provisional report of a WHO consultation. Diabet Med.
15:539–553. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Stoves J, Lindley EJ, Barnfield MC,
Burniston MT and Newstead CG: MDRD equation estimates of glomerular
filtration rate in potential living kidney donors and renal
transplant recipients with impaired graft function. Nephrol Dial
Transplant. 17:2036–2037. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Valadi H, Ekström K, Bossios A, Sjöstrand
M, Lee JJ and Lötvall JO: Exosome-mediated transfer of mRNAs and
microRNAs is a novel mechanism of genetic exchange between cells.
Nat Cell Biol. 9:654–659. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kosaka N, Iguchi H, Yoshioka Y, Takeshita
F, Matsuki Y and Ochiya T: Secretory mechanisms and intercellular
transfer of microRNAs in living cells. J Biol Chem.
285:17442–17452. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Chen X, Liang H, Zhang J, Zen K and Zhang
CY: Secreted microRNAs: A new form of intercellular communication.
Trends Cell Biol. 22:125–132. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Liu Y, Gao G, Yang C, Zhou K, Shen B,
Liang H and Jiang X: Stability of miR-126 in urine and its
potential as a biomarker for renal endothelial injury with diabetic
nephropathy. Int J Endocrinol. 2014:3931092014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Osipova J, Fischer DC, Dangwal S, Volkmann
I, Widera C, Schwarz K, Lorenzen JM, Schreiver C, Jacoby U,
Heimhalt M, et al: Diabetes-associated microRNAs in pediatric
patients with type 1 diabetes mellitus: A cross-sectional cohort
study. J Clin Endocrinol Metab. 99:E1661–E1665. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Fish JE, Santoro MM, Morton SU, Yu S, Yeh
RF, Wythe JD, Ivey KN, Bruneau BG, Stainier DY and Srivastava D:
MiR-126 regulates angiogenic signaling and vascular integrity. Dev
Cell. 15:272–284. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Zernecke A, Bidzhekov K, Noels H,
Shagdarsuren E, Gan L, Denecke B, Hristov M, Köppel T, Jahantigh
MN, Lutgens E, et al: Delivery of microRNA-126 by apoptotic bodies
induces CXCL12-dependent vascular protection. Sci Signal.
2:ra812009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Harvey SJ, Jarad G, Cunningham J, Goldberg
S, Schermer B, Harfer BD, McManus MT, Benzing T and Miner JH:
Podocyte-specific deletion of dicer alters cytoskeletal dynamics
and causes glomerular disease. J Am Soc Nephrol. 19:2150–2158.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Meng S, Cao JT, Zhang B, Zhou Q, Shen CX
and Wang CQ: Downregulation of microRNA-126 in endothelial
progenitor cells from diabetes patients, impairs their functional
properties, via target gene Spred-1. J Mol Cell Cardiol. 53:64–72.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Harris TA, Yamakuchi M, Ferlito M, Mendell
JT and Lowenstein CJ: MicroRNA-126 regulates endothelial expression
of vascular cell adhesion molecule 1. Proc Natl Acad Sci USA.
105:1516–1521. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Lagos-Quintana M, Rauhut R, Yalcin A,
Meyer J, Lendeckel W and Tuschl T: Identification of
tissue-specific microRNAs from mouse. Curr Biol. 12:735–739. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Jiang Y, Wang HY, Li Y, Guo SH, Zhang L
and Cai JH: Peripheral blood miRNAs as a biomarker for chronic
cardiovascular diseases. Sci Rep. 4:50262014.PubMed/NCBI
|
|
44
|
Asgeirsdóttir SA, van Solingen C, Kurniati
NF, Zwiers PJ, Heeringa P, van Meurs M, Satchell SC, Saleem MA,
Mathieson PW, Banas B, et al: MicroRNA-126 contributes to renal
microvascular heterogeneity of VCAM-1 protein expression in acute
inflammation. Am J Physiol Renal Physiol. 302:F1630–F1639. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hostetter TH: Prevention of the
development and progression of renal disease. J Am Soc Nephrol.
14(7 Suppl 2): S144–S147. 2003. View Article : Google Scholar : PubMed/NCBI
|
